Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
Genetic Sequencing of Advanced Pancreatic Cancer Enables Personalized Medicine
Dr. Brian Wolpin has found that about 1/3 of pancreatic cancer patients may benefit from genetic sequencing to determine treatment.
Organoids Accurately Predict Treatment Response of Pancreatic Cancer Patients
An international team of researchers led by Dr. David Tuveson has found that organoids can predict how pancreatic cancer patients will respond to different treatments.
Lustgarten Foundation Appoints David Tuveson, M.D., Ph.D., Chief Scientist
Dr. David Tuveson has been appointed the chief scientist for the Lustgarten Foundation. He specializes in pancreatic cancer reseach at the Cold Spring Harbor Labs.
Let’s Win Launches Online Video Series Featuring Long-Term Pancreatic Cancer Survivors
Meet long-term survivors of pancreatic cancers, in our new Survivors Video Series. The introductory video was launched in January at a cancer symposium.
Let’s Win and Partners Present Poster and Abstract at Gastrointestinal Cancer Symposium
"Introduction of #PancChat: A novel Twitter platform to inform and engage the pancreatic cancer community" at the 2018 Gastrointestinal Cancers…
New CancerSEEK Test Greater than 99 Percent Specific for Pancreatic Cancer
Dr. Anne Marie Lennon and colleagues have developed a blood screening test that can detect early cancer in eight organs, including the pancreas.
Keytruda Runner-Up for Science Breakthrough of the Year
The Lustgarten Foundation shares the story that Keytruda (pembrolizumab) is a runner-up in Science magazine’s Breakthrough of the year.
Lustgarten Foundation and Stand Up To Cancer Announce Two New Pancreatic Cancer Research Projects
The Lustgarten Foundation and Stand Up To Cancer announced the launch of two new pancreatic cancer interception research projects.
Faces of Let’s Win: Dr. David Tuveson
Dr. David Tuveson, M.D., Ph.D., Director of the Lustgarten Foundation Pancreatic Research Laboratory at Cold Spring Harbor Laboratory, explains why pancreatic cancer is so difficult to treat.
